These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35853537)
1. miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC. Arora S; Singh P; Tabassum G; Dohare R; Syed MA Free Radic Biol Med; 2022 Aug; 189():71-84. PubMed ID: 35853537 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. Wang Z; Qu H; Gong W; Liu A IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914 [TBL] [Abstract][Full Text] [Related]
3. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury. Ueda N Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370 [TBL] [Abstract][Full Text] [Related]
4. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death. Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173 [TBL] [Abstract][Full Text] [Related]
7. Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer. Lin Z; Li Y; Han X; Fu Z; Tian Z; Li C Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361531 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256 [TBL] [Abstract][Full Text] [Related]
9. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. Maceyka M; Sankala H; Hait NC; Le Stunff H; Liu H; Toman R; Collier C; Zhang M; Satin LS; Merrill AH; Milstien S; Spiegel S J Biol Chem; 2005 Nov; 280(44):37118-29. PubMed ID: 16118219 [TBL] [Abstract][Full Text] [Related]
10. ZNF674-AS1 antagonizes miR-423-3p to induce G0/G1 cell cycle arrest in non-small cell lung cancer cells. Liu Y; Huang R; Xie D; Lin X; Zheng L Cell Mol Biol Lett; 2021 Feb; 26(1):6. PubMed ID: 33618674 [TBL] [Abstract][Full Text] [Related]
11. [Sphingosine kinase 1 and tumor]. Zhang CX; He HW; Shao RG Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963 [TBL] [Abstract][Full Text] [Related]
12. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth. Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279 [TBL] [Abstract][Full Text] [Related]
13. LncRNA PSMG3AS1 promotes proliferation of non-small cell lung cancer cells by sponging miR-613 to upregulate SphK1. Shen W; Hong X; Jin C; Xi Y Cell Cycle; 2021 May; 20(9):829-838. PubMed ID: 33849377 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351 [TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072 [TBL] [Abstract][Full Text] [Related]
17. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4. Feng H; Ge F; Du L; Zhang Z; Liu D J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581 [TBL] [Abstract][Full Text] [Related]
18. Targeting SphK1 as a new strategy against cancer. Shida D; Takabe K; Kapitonov D; Milstien S; Spiegel S Curr Drug Targets; 2008 Aug; 9(8):662-73. PubMed ID: 18691013 [TBL] [Abstract][Full Text] [Related]
19. [The effect and mechanism of sphingosine kinase-1 knockdown on non-small cell lung cancer cell proliferation and mitochondrial apoptotic pathway]. Cao YH; Yin W; Lyu YR Sheng Li Xue Bao; 2021 Dec; 73(6):893-900. PubMed ID: 34961863 [TBL] [Abstract][Full Text] [Related]
20. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]